148 related articles for article (PubMed ID: 37137862)
1. [Natural history of chronic hepatitis B virus infection under low-level viremia].
Yan MM; Sun LH
Zhonghua Gan Zang Bing Za Zhi; 2023 Mar; 31(3):322-326. PubMed ID: 37137862
[TBL] [Abstract][Full Text] [Related]
2. [Analysis of efficacy and factors influencing sequential combination therapy with tenofovir alafenamide fumarate after treatment with entecavir in chronic hepatitis B patients with low-level viremia].
Liu LP; Wu XP; Cai TP; Wang L; Sun J; Liang JY; Ma SP; Gan X; Ruan NH; Ge SF
Zhonghua Gan Zang Bing Za Zhi; 2023 Feb; 31(2):118-125. PubMed ID: 37137825
[No Abstract] [Full Text] [Related]
3. Hepatitis B virus DNA levels and overall survival in hepatitis B-related hepatocellular carcinoma patients with low-level viremia.
Kim TS; Sinn DH; Kang W; Gwak GY; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW
J Gastroenterol Hepatol; 2019 Nov; 34(11):2028-2035. PubMed ID: 31157456
[TBL] [Abstract][Full Text] [Related]
4. New therapeutic options for persistent low-level viremia in patients with chronic hepatitis B virus infection: Increase of entecavir dosage.
Yin GQ; Li J; Zhong B; Yang YF; Wang MR
World J Gastroenterol; 2021 Feb; 27(8):666-676. PubMed ID: 33716446
[TBL] [Abstract][Full Text] [Related]
5. Low-level viremia and the increased risk of hepatocellular carcinoma in patients receiving entecavir treatment.
Kim JH; Sinn DH; Kang W; Gwak GY; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW
Hepatology; 2017 Aug; 66(2):335-343. PubMed ID: 28012257
[TBL] [Abstract][Full Text] [Related]
6. Outcome of untreated low-level viremia versus antiviral therapy-induced or spontaneous undetectable HBV-DNA in compensated cirrhosis.
Huang DQ; Tamaki N; Lee HW; Park SY; Lee YR; Lee HW; Lim SG; Lim TS; Kurosaki M; Marusawa H; Mashiba T; Kondo M; Uchida Y; Kobashi H; Furuta K; Izumi N; Kim BK; Sinn DH
Hepatology; 2023 May; 77(5):1746-1756. PubMed ID: 36633913
[TBL] [Abstract][Full Text] [Related]
7. [Demographic characteristics and associated influencing factors in treated patients with chronic hepatitis B with hypoviremia : a single-center retrospective cross-sectional study].
Li T; Kong Y; Liu YY; Liu TF; Ma AD; Li LQ; Pei ZY; Zhang LY
Zhonghua Gan Zang Bing Za Zhi; 2023 Jan; 31(1):42-48. PubMed ID: 36948848
[No Abstract] [Full Text] [Related]
8. [A possible mechanism for low-level viremia occurrence in nucleos(t)ide analog-treated chronic hepatitis B patients].
Wang LJ; Gu ZQ; Xu ZM; Chen XM; Lu FM
Zhonghua Gan Zang Bing Za Zhi; 2021 Dec; 29(12):1151-1155. PubMed ID: 35045629
[TBL] [Abstract][Full Text] [Related]
9. Low-level viremia and cirrhotic complications in patients with chronic hepatitis B according to adherence to entecavir.
Lee SB; Jeong J; Park JH; Jung SW; Jeong ID; Bang SJ; Shin JW; Park BR; Park EJ; Park NH
Clin Mol Hepatol; 2020 Jul; 26(3):364-375. PubMed ID: 32466635
[TBL] [Abstract][Full Text] [Related]
10. Decreased neonatal hepatitis B virus (HBV) viremia by maternal tenofovir treatment predicts reduced chronic HBV infection in children born to highly viremic mothers.
Chang KC; Chang MH; Lee CN; Chang CH; Wu JF; Ni YH; Wen WH; Shyu MK; Lai MW; Chen SM; Hu JJ; Lin HH; Hsu JJ; Mu SC; Lin YC; Liu CJ; Chen DS; Lin LH; Chen HL;
Aliment Pharmacol Ther; 2019 Aug; 50(3):306-316. PubMed ID: 31271463
[TBL] [Abstract][Full Text] [Related]
11. CRISPR/Cas13a-assisted rapid and portable HBV DNA detection for low-level viremia patients.
Tian Y; Fan Z; Xu L; Cao Y; Chen S; Pan Z; Gao Y; Li H; Zheng S; Ma Y; Duan Z; Zhang X; Ren F
Emerg Microbes Infect; 2023 Dec; 12(1):e2177088. PubMed ID: 36735916
[TBL] [Abstract][Full Text] [Related]
12. [Low-level viremia-induced liver fibrosis and hepatocellular carcinoma in chronic hepatitis B].
Lu ZZ; Sun YM; You H
Zhonghua Gan Zang Bing Za Zhi; 2021 Dec; 29(12):1144-1146. PubMed ID: 35045627
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B virus infection--natural history and clinical consequences.
Ganem D; Prince AM
N Engl J Med; 2004 Mar; 350(11):1118-29. PubMed ID: 15014185
[No Abstract] [Full Text] [Related]
14. [Research status and challenges of low-level viremia in chronic hepatitis B].
Hu P
Zhonghua Gan Zang Bing Za Zhi; 2021 Dec; 29(12):1137-1138. PubMed ID: 35045625
[TBL] [Abstract][Full Text] [Related]
15. [Very low-level viremia: new clinical attention-requiring problem during the course of anti-hepatitis B virus treatment].
Shi YJ; Ding Y; Ao L; Zhang DZ; Cai DC
Zhonghua Gan Zang Bing Za Zhi; 2021 Dec; 29(12):1147-1150. PubMed ID: 35045628
[TBL] [Abstract][Full Text] [Related]
16. Big Data Information under Proportional Hazard Mathematical Model in Analysis of Hepatitis B Virus Infection Data of Patients with Interventional Liver Cancer through Antiviral Therapy of Entecavir.
Zhang Y; Zhao S; Ding H; Song X; Miao H; Cui X; Wang J; Han B
J Healthc Eng; 2021; 2021():6225403. PubMed ID: 34976330
[TBL] [Abstract][Full Text] [Related]
17. Management of acute hepatitis B and reactivation of hepatitis B.
Jindal A; Kumar M; Sarin SK
Liver Int; 2013 Feb; 33 Suppl 1():164-75. PubMed ID: 23286861
[TBL] [Abstract][Full Text] [Related]
18. Post-operative recurrence of liver cancer according to antiviral therapy for detectable hepatitis B viremia: A nationwide study.
Yun B; Ahn SH; Oh J; Yoon JH; Kim BK
Eur J Intern Med; 2023 Jan; 107():66-72. PubMed ID: 36347739
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of antiviral therapy in untreated compensated cirrhosis patient with serum HBV-DNA level < 2000 IU/mL.
Lee H; Jang S; Ahn SH; Kim BK
Hepatol Int; 2022 Apr; 16(2):294-305. PubMed ID: 35322374
[TBL] [Abstract][Full Text] [Related]
20. Correlation between low-level viremia and hepatitis B-related hepatocellular carcinoma and recurrence: a retrospective study.
Sun F; Liu Z; Wang B
BMC Cancer; 2021 Oct; 21(1):1103. PubMed ID: 34649509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
